focus -WSS

focus

author：focus 2025-10-03 00:06:53 - browse：83

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： 5 takeaways from STAT's examination of Zynex Medical

hotspot

WSS

California wildfire smoke linked to 52,000 early deaths, study says

Medical device trials still don't enroll enough women, study finds

What to know about OceanGate, the company behind the missing Titanic submersible

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

It's time to get medical device identifiers over the finish line

My daughter's legacy lives on through her writing, phage therapy

knowledge

focus

focus

Wildfire smoke exposes gaps in outdoor worker protections

How the political right came to back psychedelics to treat trauma

BioMarin wins approval for gene therapy to treat hemophilia A

Teladoc has a new CEO, but challenges remain the same

After affirmative action ruling, medical educators look to 'holistic review'

Statins may not be needed by millions of people, study suggests

Jerome Adams on the need for new antivirals for Covid

Living with Fabry disease, a condition that causes chronic pain

Peter Hotez and the public health issue of online harassment

NIH tests clinical research in primary care with $30 million program

focus

NIH tests clinical research in primary care with $30 million program

ALS patient reclaims some autonomy thanks to wearable 'robot'

NIH tests clinical research in primary care with $30 million program

Teladoc has a new CEO, but challenges remain the same

Readers discuss the intersection of pregnancy and addiction

Report captures long Covid’s disabling effects and policy challenges

leisure time

Wikipedia

hotspot

focus